title: Intrabursal injection of clodronate liposomes causes macrophage depletion and inhibits ovulation in the mouse ovary.
abstract: To investigate the role of the ovarian macrophage population in ovulation, we examined the effect of depleting this population using liposome-encapsulated clodronate. Clodronate liposomes, saline liposomes, or saline alone was injected under the ovarian bursa in gonadotropin-primed adult mice, either 84 h (Day -3) or 36 h (Day -1) before ovulation. Ovulation rates were determined by counting the number of oocytes released. The numbers of graafian follicles and corpora lutea were also counted immediately before and after ovulation. Macrophage distribution within the theca and stroma of preovulatory ovaries was examined by immunohistochemistry with specific monoclonal antibodies to the macrophage antigens macrosialin, major histocompatability complex class II (Ia), and F4/80. Injection of clodronate liposomes on Day -1 did not affect ovulation rates, whereas administration on Day -3 caused a significant reduction in ovulation rate (mean oocytes ovulated = 5. 25 +/- 0.6 from clodronate liposome-treated ovaries and 9.13 +/- 0.9 from saline-treated ovaries, respectively, P < 0.05). The numbers of macrosialin-positive macrophages present in the theca at ovulation were reduced by treatment with clodronate liposomes on Day -1, and treatment on Day -3 reduced the numbers of Ia-positive and macrosialin-positive macrophages present in the theca. When the subsequent ovarian cycles were examined by vaginal smearing, the metestrous-2/diestrous stage was found to be extended in clodronate liposome-treated animals (7.5 +/- 1.3 days vs. 3.4 +/- 0.4 days for saline liposome-treated animals, P < 0.05). These results suggest that thecal macrophages may be involved in the regulation of follicular growth and rupture, as well as being important for the normal progression of the estrous cycle.
authors.affiliation: Reproductive Medicine Unit, Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.
authors.forename: K H
authors.initials: KH
authors.lastname: Van der Hoek
authors.forename: S
authors.initials: S
authors.lastname: Maddocks
authors.forename: C M
authors.initials: CM
authors.lastname: Woodhouse
authors.forename: N
authors.initials: N
authors.lastname: van Rooijen
authors.forename: S A
authors.initials: SA
authors.lastname: Robertson
authors.forename: R J
authors.initials: RJ
authors.lastname: Norman
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D004002:Clodronic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D004337:Drug Carriers; D004971:Estrus / Q000187:drug effects / Q000502:physiology; D005260:Female; D007150:Immunohistochemistry; D007267:Injections; D008081:Liposomes; D008264:Macrophages / Q000187:drug effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D009865:Oocytes / Q000502:physiology; D006080:Ovarian Follicle / Q000502:physiology; D010053:Ovary / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects*; D010060:Ovulation / Q000187:drug effects*
chemical_list: D018712:Analgesics, Non-Narcotic; D004337:Drug Carriers; D008081:Liposomes; D004002:Clodronic Acid